Literature DB >> 85869

1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.

S E Papapoulos, T L Clemens, L J Fraher, I G Lewin, L M Sandler, J L O'Riordan.   

Abstract

A 36-year-old man with sarcoidosis had four episodes of hypercalcaemia in seven years, all of them during the summer months. Measurement over three years showed that hypercalcaemia was associated with small seasonal increases in serum-25-hydroxycholecalciferol within the normal range. These changes could be mimicked by the administration of 3000 units of vitamin D3 daily. Serum 1, 25-dihydroxycholecalciferol concentrations ranged between 26--62 pg/ml when serum calcium was normal, but were strikingly high, up to 137 pg/ml, when the patient was hypercalcaemic. These studies show for the first time that hypercalcaemia in sarcoidosis is associated with abnormally high circulating concentrations of 1, 25-dihydroxycholecalciferol, probably as a result of overproduction of this, the hormonal form of vitamin D.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 85869     DOI: 10.1016/s0140-6736(79)91076-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  44 in total

1.  Intermittent hypercalcaemia and vitamin D sensitivity in Hodgkin's disease.

Authors:  R Karmali; S Barker; M Hewison; L Fraher; D R Katz; J L O'Riordan
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

2.  Vitamin-D status and mineral metabolism in two ethnic populations with sarcoidosis.

Authors:  Giovanna Capolongo; Li Hao Richie Xu; Mariasofia Accardo; Alessandro Sanduzzi; Anna Agnese Stanziola; Annamaria Colao; Carlo Agostini; Miriam Zacchia; Giovambattista Capasso; Beverley Adams-Huet; Orson W Moe; Naim M Maalouf; Khashayar Sakhaee; Connie C W Hsia
Journal:  J Investig Med       Date:  2016-04-06       Impact factor: 2.895

Review 3.  Clinical impact of bone and calcium metabolism changes in sarcoidosis.

Authors:  G Rizzato
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

Review 4.  Vitamin D-endocrine system.

Authors:  N H Bell
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

Review 5.  The skull in chronic sarcoidosis.

Authors:  D Landsberger; D Rav'e; G Friedman
Journal:  Postgrad Med J       Date:  1988-11       Impact factor: 2.401

Review 6.  Calcium and vitamin D metabolism in granulomatous diseases.

Authors:  M Fuss; T Pepersack; C Gillet; R Karmali; J Corvilain
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

Review 7.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

8.  Increased parathyroid hormone in a patient with sarcoidosis and hypercalcemia.

Authors:  H Franck; R Hehrmann; E Keck; H L Krüskemper
Journal:  Klin Wochenschr       Date:  1987-08-03

Review 9.  Therapeutic applications of vitamin D analogues.

Authors:  J Reeve
Journal:  Br Med J       Date:  1979-10-13

10.  Nephrolithiasis as a presenting feature of chronic sarcoidosis.

Authors:  G Rizzato; P Fraioli; L Montemurro
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.